@article{cbcd51eef2314e78b323d920d120c43d,
title = "Editorial: gamma delta T Cells in Cancer: γδ T Cells in Cancer",
keywords = "bisphoshonates, butyrophilin, cancer, immunotherapy, γδ T cells, gamma delta T cells",
author = "Coffelt, \{Seth B.\} and Dieter Kabelitz and Bruno Silva-Santos and Jurgen Kuball and Willi Born and Ilan Bank",
note = "Funding Information: The authors acknowledge funding from the Cancer Research UK Glasgow Centre (A25142 to SBC), the Wellcome Trust (208990/ Z/17/Z to SBC), the Medical Research Council (MR/R502327/1 to SBC), Breast Cancer Now (2018JulPR1101 and 2019DecPhD1349 to SBC), Tenovus Scotland (S17-17 to SBC), the Deutsche Forschungsgemeinschaft (Ka 502/19-2 to DK), the Wilhelm Sander Foundation (2018.045.1 to DK), “la Caixa” Banking Foundation (HR18-00069 to BS-S), the Dutch Research Council (NWO ZonMW 43400003 to JK), the Dutch Cancer Society (KWF UU 2014-6790, UU 2015-7601, UU 2018-11393, UU 2018-11979, UU 2019-12586, UU 2020-13043 to JK). Copyright: Copyright 2020 Elsevier B.V., All rights reserved.",
year = "2020",
month = nov,
day = "20",
doi = "10.3389/fimmu.2020.602411",
language = "English",
volume = "11",
pages = "1--3",
journal = "Frontiers in Immunology",
issn = "1664-3224",
publisher = "Frontiers Media S. A.",
}